D. Diagnostique and E. , 87 IV.2.a) Délai diagnostique moyen : Objectif principal

M. Bonduelle, Charcot, dates, legend and reality, Hist Sci Medicales, vol.28, issue.4, pp.289-95, 1994.

C. Bell, A case of partial wasting of the muscles of the upper extremities In: The nervous system of the human body

F. Aran, Recherches sur une maladie non encore décrite du système musculaire (atrophie musculaire progressive), Arch Gen Med, vol.24, issue.535, pp.172-214, 1850.

G. Duchenne-de-boulogne, De l'électrisation localisée et de son application à la pathologie et à la thérapeutique

J. Cruveilhier, Sur la paralysie musculaire, progressive, atrophique, Bull Acad Med, vol.18, pp.490-502546, 1853.

J. Charcot and A. Joffroy, Deux cas d'atrophie musculaire progressive avec lésions de la substance grise et des faisceaux antéro-latéraux de la moelle épinière, Arch Physio Norm Pathol, vol.2, pp.354-67744, 1869.

L. Rowland, How Amyotrophic Lateral Sclerosis Got Its Name, Archives of Neurology, vol.58, issue.3, pp.512-517, 2001.
DOI : 10.1001/archneur.58.3.512

M. Kiernan, S. Vucic, B. Cheah, M. Turner, A. Eisen et al., Amyotrophic lateral sclerosis. The Lancet, pp.942-55, 2011.

S. Mathis, P. Couratier, A. Julian, J. Vallat, P. Corcia et al., Management and therapeutic perspectives in amyotrophic lateral sclerosis, Expert Review of Neurotherapeutics, vol.11, issue.3, pp.263-76, 2017.
DOI : 10.1007/s00415-014-7424-6

M. Soriani and C. Desnuelle, ??pid??miologie de la SLA, Revue Neurologique, vol.165, issue.8-9, pp.8-9627, 2009.
DOI : 10.1016/j.neurol.2009.04.004

P. Couratier, B. Marin, G. Lautrette, M. Nicol, and P. Preux, ??pid??miologie, spectre clinique de la SLA et diagnostics diff??rentiels, La Presse M??dicale, vol.43, issue.5, pp.538-586, 2014.
DOI : 10.1016/j.lpm.2014.02.013

A. Rosenbohm, R. Peter, S. Erhardt, D. Lulé, D. Rothenbacher et al., Epidemiology of amyotrophic lateral sclerosis in Southern Germany, Journal of Neurology, vol.11, issue.7, pp.749-57, 2017.
DOI : 10.1038/ncomms12408

B. Marin, F. Boumédiene, G. Logroscino, P. Couratier, M. Babron et al., Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis, International Journal of Epidemiology, vol.46, issue.1, pp.57-74, 2017.
DOI : 10.1093/ije/dyw061

URL : https://hal.archives-ouvertes.fr/hal-01320274

S. Waring, C. Esteban-santillan, D. Reed, U. Craig, D. Labarthe et al., Incidence of Amyotrophic Lateral Sclerosis and of the Parkinsonism-Dementia Complex of Guam, 1950???1989, Neuroepidemiology, vol.23, issue.4, pp.192-200, 1950.
DOI : 10.1159/000078505

F. Torny, M. Lacoste, J. Nguyen, M. Tymoczko-nguyen, and P. Couratier, ??tude des causes du retard au diagnostic de la scl??rose lat??rale amyotrophique, Revue Neurologique, vol.162, issue.5, pp.617-639, 2006.
DOI : 10.1016/S0035-3787(06)75055-X

B. Brooks, Diagnostic dilemmas in amyotrophic lateral sclerosis, Journal of the Neurological Sciences, vol.165, issue.1, pp.1-9, 1999.
DOI : 10.1016/S0022-510X(99)00019-2

A. Calvo, C. Moglia, C. Lunetta, K. Marinou, N. Ticozzi et al., Factors predicting survival in ALS: a multicenter Italian study, Journal of Neurology, vol.77, issue.1, pp.54-63, 2017.
DOI : 10.1212/WNL.0b013e318232ab9b

O. Hardiman, A. Chalabi, C. Brayne, E. Beghi, . Van-den et al., The changing picture of amyotrophic lateral sclerosis: lessons from European registers, Journal of Neurology, Neurosurgery & Psychiatry, vol.250, issue.7, pp.2016-314495, 2017.
DOI : 10.1136/jnnp-2016-314495

B. Yu and R. Pamphlett, Environmental insults: critical triggers for amyotrophic lateral sclerosis, Translational Neurodegeneration, vol.130, issue.Pt 7, p.15, 2017.
DOI : 10.1093/brain/awm190

J. Gil, B. Funalot, F. Torny, M. Lacoste, and P. Couratier, Facteurs de risque exog??nes de la scl??rose lat??rale amyotrophique sporadique, Revue Neurologique, vol.163, issue.11, pp.1021-1051, 2007.
DOI : 10.1016/S0035-3787(07)74174-7

S. Banack and P. Cox, Biomagnification of cycad neurotoxins in flying foxes:, Neurology, vol.61, issue.3, pp.387-396, 2003.
DOI : 10.1212/01.WNL.0000078320.18564.9F

A. Malek, A. Barchowsky, R. Bowser, A. Youk, and E. Talbott, Pesticide exposure as a risk factor for amyotrophic lateral sclerosis: A meta-analysis of epidemiological studies, Environmental Research, vol.117, pp.112-121, 2012.
DOI : 10.1016/j.envres.2012.06.007

F. Kamel, D. Umbach, H. Hu, T. Munsat, J. Shefner et al., Lead Exposure as a Risk Factor for Amyotrophic Lateral Sclerosis, Neurodegenerative Diseases, vol.109, issue.3-4, pp.195-201, 2005.
DOI : 10.1002/mus.10000

L. Dauphine, Un taux exceptionnel de cas de maladie de Charcot dans deux petites communes [Internet]. [cité 14 sept 2017] Disponible sur

. The-huffington-post-québec, La SLA: une «jeune» maladie avec encore bien des mystères [Internet], Disponible sur, 2017.

C. Harwood, K. Westgate, S. Gunstone, S. Brage, N. Wareham et al., Long-term physical activity: an exogenous risk factor for sporadic amyotrophic lateral sclerosis? Amyotroph Lateral Scler Front Degener, pp.377-84, 2016.

M. Gotkine, Y. Friedlander, and H. Hochner, Triathletes are over-represented in a population of patients with ALS, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol.41, issue.7-8, pp.534-540, 2014.
DOI : 10.1159/000350015

A. Chiò, G. Benzi, M. Dossena, R. Mutani, and G. Mora, Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players, Brain, vol.128, issue.3, pp.472-478, 2005.
DOI : 10.1093/brain/awh373

O. Piazza, A. Sirén, and H. Ehrenreich, Soccer, neurotrauma and amyotrophic lateral sclerosis: is there a connection?, Current Medical Research and Opinion, vol.20, issue.4, pp.505-513, 2004.
DOI : 10.1185/030079904125003296

R. Horner, S. Grambow, C. Coffman, J. Lindquist, E. Oddone et al., Amyotrophic Lateral Sclerosis among 1991 Gulf War Veterans: Evidence for a Time-Limited Outbreak, Neuroepidemiology, vol.31, issue.1, pp.28-32, 2008.
DOI : 10.1159/000136648

M. Feychting, F. Jonsson, N. Pedersen, and A. Ahlbom, Occupational Magnetic Field Exposure and Neurodegenerative Disease, Epidemiology, vol.14, issue.4, pp.413-419, 2003.
DOI : 10.1097/01.EDE.0000071409.23291.7b

H. Fischer, L. Kheifets, A. Huss, T. Peters, R. Vermeulen et al., Occupational Exposure to Electric Shocks and Magnetic Fields and Amyotrophic Lateral Sclerosis in Sweden, Epidemiology, vol.26, issue.6, pp.824-854, 2015.
DOI : 10.1097/EDE.0000000000000365

L. Nelson, V. Mcguire, W. Longstreth, and C. Matkin, Population-Based Case-Control Study of Amyotrophic Lateral Sclerosis in Western Washington State. I. Cigarette Smoking and Alcohol Consumption, American Journal of Epidemiology, vol.151, issue.2, pp.156-63, 2000.
DOI : 10.1093/oxfordjournals.aje.a010183

B. Jubelt and H. Lipton, ALS: Persistent scientists do not find persisting enteroviruses, Neurology, vol.62, issue.8, pp.1250-1251, 2004.
DOI : 10.1212/01.WNL.0000126187.03971.BA

O. Hardiman and M. Greenway, The complex genetics of amyotrophic lateral sclerosis, The Lancet Neurology, vol.6, issue.4, pp.291-293, 2007.
DOI : 10.1016/S1474-4422(07)70062-5

A. Bush, Is ALS caused by an altered oxidative activity of mutant superoxide dismutase?, Nature Neuroscience, vol.272, issue.10, p.919, 2002.
DOI : 10.1074/jbc.272.38.23469

C. Vial, Quels sont les crit??res cliniques de SLA en fonction des formes cliniques ?, Revue Neurologique, vol.162, issue.2, pp.25-33, 2006.
DOI : 10.1016/S0035-3787(06)75161-X

D. Trotti, M. Aoki, P. Pasinelli, U. Berger, N. Danbolt et al., Amyotrophic Lateral Sclerosis-linked Glutamate Transporter Mutant Has Impaired Glutamate Clearance Capacity, Journal of Biological Chemistry, vol.3, issue.1, pp.576-82, 2001.
DOI : 10.1016/S0896-6273(00)80272-X

J. Delatre, J. Beaudeux, and D. Bonnefont-rousselot, Radicaux libres et stress oxydant: Aspects biologiques et pathologiques, 2007.

S. Mathis, P. Couratier, A. Julian, P. Corcia, L. Masson et al., Current view and perspectives in amyotrophic lateral sclerosis, Neural Regeneration Research, vol.12, issue.2, pp.181-185, 2017.
DOI : 10.4103/1673-5374.200794

B. Freibaum and J. Taylor, The Role of Dipeptide Repeats in C9ORF72-Related ALS-FTD, Frontiers in Molecular Neuroscience, vol.110, p.35, 2017.
DOI : 10.1073/pnas.1315438110

R. Whittaker, The fundamentals of electromyography, Practical Neurology, vol.12, issue.3, pp.187-94, 2012.
DOI : 10.1136/practneurol-2011-000198

A. Guennoc, W. Camu, and P. Corcia, Les crit??res d???Awaji??: les nouveaux crit??res diagnostiques de la scl??rose lat??rale amyotrophique, Revue Neurologique, vol.169, issue.6-7, pp.6-7470, 2013.
DOI : 10.1016/j.neurol.2012.10.007

S. Bresch, E. Delmont, M. Soriani, and C. Desnuelle, Apport de l?????lectromyogramme dans le diagnostic pr??coce des SLA ?? d??but bulbaire??: comparaison des crit??res d???El Escorial, d???El Escorial modifi??s et d???Awaji, Revue Neurologique, vol.170, issue.2, pp.134-143, 2014.
DOI : 10.1016/j.neurol.2013.10.004

B. Brooks, El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis, Journal of the Neurological Sciences, vol.124, pp.96-107, 1994.
DOI : 10.1016/0022-510X(94)90191-0

B. Brooks, R. Miller, M. Swash, and T. Munsat, El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis, Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, vol.1, issue.5, pp.293-302, 2000.
DOI : 10.1080/146608200300079536

D. Carvalho, M. Dengler, R. Eisen, A. England, J. Kaji et al., Electrodiagnostic criteria for diagnosis of ALS, Clinical Neurophysiology, vol.119, issue.3, pp.497-503, 2008.
DOI : 10.1016/j.clinph.2007.09.143

D. Carvalho, M. Swash, and M. , Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis, Amyotrophic Lateral Sclerosis, vol.21, issue.5, pp.53-60, 2009.
DOI : 10.1002/(SICI)1097-4598(199803)21:3<336::AID-MUS7>3.0.CO;2-B

P. Cintas and . Les, Awaji pour le diagnostic de la sclérose latérale amlyotrophique : raisons et critiques [Internet]. [cité 14 sept 2017] Disponible sur: http://www.edimark.fr/Front/frontpost/getfiles/18174.pdf 54. HAS. Recommandations professionnelles : Prise en charge des personnes atteintes de sclérose latérale amyotrophique

E. Fournier, E. Electrodiagnosis, and E. , what do the future and the past tell us about the present?, Rev Med Liege, vol.59, issue.1, pp.3-14, 2004.

B. Eymard, La myasthénie du côté de l'interniste. Rev Médecine Interne, juill, vol.35, issue.7, pp.421-430, 2014.

E. Farbu, Update on current and emerging treatment options for post-polio syndrome, Therapeutics and Clinical Risk Management, vol.6, pp.307-320, 2010.
DOI : 10.2147/TCRM.S4440

A. Lagueny, Le syndrome crampes-fasciculations, Rev Neurol. déc, vol.161, pp.1260-1266, 2005.

S. Mathis, P. Dumas, J. Neau, and R. Gil, La neuropathie motrice pure, une??complication rare de??la??radioth??rapie: trois??observations et??une??revue de??la??litt??rature, La Revue de M??decine Interne, vol.28, issue.6, pp.377-87, 2007.
DOI : 10.1016/j.revmed.2007.01.025

H. Willison, B. Jacobs, and P. Van-doorn, Guillain-Barré syndrome. The Lancet. 13 août 2016, pp.717-744, 10045.

C. Masson, D. Leys, J. Meder, V. Dousset, and J. Pruvo, Isch??mie m??dullaire, Journal of Neuroradiology, vol.31, issue.1, pp.35-46, 2004.
DOI : 10.1016/S0150-9861(04)96877-0

O. Benveniste, La myosite à inclusions. Rev Médecine Interne, juill, vol.35, issue.7, pp.472-481, 2014.

O. Danon and . Syringomyelia, Presse Medicale Paris Fr 1983, oct, vol.36, issue.10 2, pp.1516-1523, 2007.

A. Fromont and T. Moreau, Multiple sclerosis, Rev Prat. juin, vol.63, issue.6, pp.851-860, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01255824

N. Vandenberghe, F. Bouhour, P. Petiot, P. Gonnaud, P. Latour et al., L???amyotrophie bulbospinale li??e ?? l???X ou maladie de Kennedy??: variations ph??notypiques, Revue Neurologique, vol.165, issue.1, pp.31-38, 2009.
DOI : 10.1016/j.neurol.2008.06.005

P. Couratier, J. Desport, M. Antonini, T. Mabrouk, A. Perna et al., Prise en charge nutritionnelle et respiratoire des patients atteints de Scl??rose Lat??rale Amyotrophique (SLA), Revue Neurologique, vol.160, issue.2, pp.243-50, 2004.
DOI : 10.1016/S0035-3787(04)70898-X

R. Miller, J. Mitchell, and D. Moore, Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) In: Cochrane Database of Systematic Reviews, 2012.

C. Dennys, J. Armstrong, M. Levy, Y. Byun, K. Ramdial et al., Chronic inhibitory effect of riluzole on trophic factor production, Experimental Neurology, vol.271, pp.301-308, 2015.
DOI : 10.1016/j.expneurol.2015.05.016

C. Desnuelle, M. Dib, C. Garrel, and A. Favier, A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group, Amyotroph Lateral Scler Mot Neuron Disord. mars, vol.2, issue.1, pp.9-18, 2001.

L. Mazzini, T. Corrà, M. Zaccala, G. Mora, M. Piano et al., Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis, Journal of Neurology, vol.124, issue.10, pp.695-703, 1995.
DOI : 10.1007/BF00866922

T. Jenkins, H. Hollinger, and C. Mcdermott, The evidence for symptomatic treatments in amyotrophic lateral sclerosis, Current Opinion in Neurology, vol.27, issue.5, pp.524-555, 2014.
DOI : 10.1097/WCO.0000000000000135

S. Bourke, M. Tomlinson, T. Williams, R. Bullock, P. Shaw et al., Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial, The Lancet Neurology, vol.5, issue.2, pp.140-147, 2006.
DOI : 10.1016/S1474-4422(05)70326-4

J. Gonzalez-bermejo, Scl??rose lat??rale amyotrophique??: quand proposer une ventilation artificielle???, Revue des Maladies Respiratoires, vol.25, issue.8, pp.1059-60, 2008.
DOI : 10.1016/S0761-8425(08)74428-0

P. Andersen, S. Abrahams, G. Borasio, D. Carvalho, M. Chio et al., EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-revised report of an EFNS task force, Eur J Neurol. mars, vol.19, issue.3, pp.360-75, 2012.

P. Fraisse, Le dispositif d???annonce en canc??rologie : entre ??thique et pratique, Revue des Maladies Respiratoires, vol.24, issue.5, pp.569-74, 2007.
DOI : 10.1016/S0761-8425(07)91123-7

J. Pouget and . Les, Centres dédiés à la sclérose latérale amyotrophique ont-ils changé les pratiques et la prise en charge ? Rev Neurol (Paris), févr, vol.169, pp.39-44, 2013.

B. Traynor, A. M. Corr, B. Frost, E. Hardiman, and O. , Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000, Journal of Neurology, Neurosurgery & Psychiatry, vol.74, issue.9, pp.1258-61, 1996.
DOI : 10.1136/jnnp.74.9.1258

M. Turner, M. Parton, C. Shaw, P. Leigh, and A. Chalabi, Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002, Journal of Neurology, Neurosurgery & Psychiatry, vol.74, issue.7, pp.995-1002, 2003.
DOI : 10.1136/jnnp.74.7.995

A. Czaplinski, A. Yen, E. Simpson, and S. Appel, Predictability of disease progression in amyotrophic lateral sclerosis, Muscle & Nerve, vol.5, issue.6, pp.702-710, 2006.
DOI : 10.1212/01.WNL.0000144345.49510.4E

W. Reniers, M. Schrooten, K. Claeys, P. Tilkin, D. Hondt et al., Prognostic value of clinical and electrodiagnostic parameters at time of diagnosis in patients with amyotrophic lateral sclerosis, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol.41, issue.5-6, 2017.
DOI : 10.1002/mus.21841

L. Dupuis, P. Corcia, A. Fergani, J. Gonzalez-de-aguilar, D. Bonnefont-rousselot et al., Dyslipidemia is a protective factor in amyotrophic lateral sclerosis, Neurology, vol.70, issue.13, pp.1004-1013, 2008.
DOI : 10.1212/01.wnl.0000285080.70324.27

J. Cedarbaum, N. Stambler, E. Malta, C. Fuller, D. Hilt et al., The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function, Journal of the Neurological Sciences, vol.169, issue.1-2, pp.13-21, 1999.
DOI : 10.1016/S0022-510X(99)00210-5

K. Kollewe, U. Mauss, K. Krampfl, S. Petri, R. Dengler et al., ALSFRS-R score and its ratio: A useful predictor for ALS-progression, Journal of the Neurological Sciences, vol.275, issue.1-2, pp.69-73, 2008.
DOI : 10.1016/j.jns.2008.07.016

F. Kimura, C. Fujimura, S. Ishida, H. Nakajima, D. Furutama et al., Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS, Neurology, vol.66, issue.2, pp.265-272, 2006.
DOI : 10.1212/01.wnl.0000194316.91908.8a

J. Bleton, L'évaluation musculaire manuelle par l'échelle MRC, Kinésithér Scient, vol.0547, pp.61-63, 2013.

R. Bohannon and M. Smith, Interrater Reliability of a Modified Ashworth Scale of Muscle Spasticity, Physical Therapy, vol.67, issue.2, pp.206-213, 1987.
DOI : 10.1093/ptj/67.2.206

H. Echelle and H. , Disponible sur: https, 2017.

J. Gil, B. Funalot, A. Verschueren, V. Danel-brunaud, W. Camu et al., Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study, European Journal of Neurology, vol.298, issue.Suppl. 1, pp.1245-51, 2008.
DOI : 10.1136/bmj.314.7076.271

M. Benatar, K. Boylan, A. Jeromin, S. Rutkove, J. Berry et al., ALS biomarkers for therapy development: State of the field and future directions, Muscle & Nerve, vol.6, issue.Suppl, pp.169-82, 2016.
DOI : 10.1016/j.jalz.2010.03.007

A. Czaplinski, A. Yen, E. Simpson, and S. Appel, Slower Disease Progression and Prolonged Survival in Contemporary Patients With Amyotrophic Lateral Sclerosis, Archives of Neurology, vol.63, issue.8, pp.1139-1182, 2006.
DOI : 10.1001/archneur.63.8.1139

A. Chiò, G. Mora, A. Calvo, L. Mazzini, E. Bottacchi et al., Epidemiology of ALS in Italy: A 10-year prospective population-based study, Neurology, vol.72, issue.8, pp.725-756, 2009.
DOI : 10.1212/01.wnl.0000343008.26874.d1

J. Mitchell, P. Callagher, J. Gardham, C. Mitchell, M. Dixon et al., Timelines in the diagnostic evaluation of people with suspected amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) ??? a 20-year review: Can we do better?, Amyotrophic Lateral Sclerosis, vol.34, issue.1, pp.537-578, 2010.
DOI : 10.1002/mus.20555

. Insee, Populations légales 2012 [Internet]. [cité 14 sept 2017]. Disponible sur: https

G. Logroscino, B. Traynor, O. Hardiman, A. Chiò, D. Mitchell et al., Incidence of amyotrophic lateral sclerosis in Europe, Journal of Neurology, Neurosurgery & Psychiatry, vol.81, issue.4, pp.385-90, 2010.
DOI : 10.1136/jnnp.2009.183525

K. Kollewe, S. Koerner, J. Ilsemann, B. Mohammadi, K. Krampfl et al., Nerve compression syndromes in ALS: A retrospective analysis in 554 patients, Amyotrophic Lateral Sclerosis, vol.34, issue.5, pp.349-51, 2011.
DOI : 10.1002/mus.20555

P. Corcia, P. Valdmanis, S. Millecamps, C. Lionnet, H. Blasco et al., Phenotype and genotype analysis in amyotrophic lateral sclerosis with TARDBP gene mutations, Neurology, vol.78, issue.19, pp.1519-1545, 2012.
DOI : 10.1212/WNL.0b013e3182553c88

URL : https://hal.archives-ouvertes.fr/hal-00920773

A. Chiò, ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis, Journal of Neurology, vol.244, issue.Suppl 4, pp.1-5, 1999.
DOI : 10.1212/WNL.48.4_Suppl_4.15S

M. Galvin, P. Ryan, S. Maguire, M. Heverin, C. Madden et al., The path to specialist multidisciplinary care in amyotrophic lateral sclerosis: A population- based study of consultations, interventions and costs, PLOS ONE, vol.114, issue.6, p.179796, 2017.
DOI : 10.1371/journal.pone.0179796.s001

Y. Iwasaki, K. Ikeda, and M. Kinoshita, The diagnostic pathway in amyotrophic lateral sclerosis, Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, vol.2, issue.3, pp.123-129, 2001.
DOI : 10.1080/146608201753275571

J. Belsh and P. Schiffman, The amyotrophic lateral sclerosis (ALS) patient perspective on misdiagnosis and its repercussions, Journal of the Neurological Sciences, vol.139, pp.110-116, 1996.
DOI : 10.1016/0022-510X(96)00088-3

E. Househam and M. Swash, Diagnostic delay in amyotrophic lateral sclerosis: what scope for improvement?, Journal of the Neurological Sciences, vol.180, issue.1-2, pp.76-81, 2000.
DOI : 10.1016/S0022-510X(00)00418-4

B. Traynor, M. Codd, B. Corr, C. Forde, E. Frost et al., Clinical Features of Amyotrophic Lateral Sclerosis According to the El Escorial and Airlie House Diagnostic Criteria, Archives of Neurology, vol.57, issue.8, pp.1171-1177, 2000.
DOI : 10.1001/archneur.57.8.1171

A. Chiò, G. Mora, M. Leone, L. Mazzini, D. Cocito et al., Early symptom progression rate is related to ALS outcome: A prospective population-based study, Neurology, vol.59, issue.1, pp.99-103, 2002.
DOI : 10.1212/WNL.59.1.99

S. Zoccolella, E. Beghi, G. Palagano, A. Fraddosio, V. Samarelli et al., Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: A population-based study, Journal of the Neurological Sciences, vol.250, issue.1-2, pp.45-54, 2006.
DOI : 10.1016/j.jns.2006.06.027

C. Donaghy, A. Dick, O. Hardiman, and V. Patterson, Timeliness of diagnosis in motor neurone disease: a population-based study, Ulster Med J. janv, vol.77, issue.1, pp.18-21, 2008.

M. Kraemer, M. Buerger, and P. Berlit, Diagnostic problems and delay of diagnosis in amyotrophic lateral sclerosis, Clinical Neurology and Neurosurgery, vol.112, issue.2, pp.103-108, 2010.
DOI : 10.1016/j.clineuro.2009.10.014

M. Turner, J. Scaber, J. Goodfellow, M. Lord, R. Marsden et al., The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis, Journal of the Neurological Sciences, vol.294, issue.1-2, pp.81-86, 2010.
DOI : 10.1016/j.jns.2010.03.028

E. Cellura, R. Spataro, A. Taiello, L. Bella, and V. , Factors affecting the diagnostic delay in amyotrophic lateral sclerosis, Clinical Neurology and Neurosurgery, vol.114, issue.6, pp.550-554, 2012.
DOI : 10.1016/j.clineuro.2011.11.026

J. Williams, D. Fitzhenry, L. Grant, D. Martyn, and D. Kerr, Diagnosis pathway for patients with amyotrophic lateral sclerosis: retrospective analysis of the US Medicare longitudinal claims database, BMC Neurology, vol.69, issue.Suppl 3, p.160, 2013.
DOI : 10.1001/archneurol.2012.254

H. Nzwalo, D. Abreu, D. Swash, M. Pinto, S. et al., Delayed diagnosis in ALS: The problem continues, Journal of the Neurological Sciences, vol.343, issue.1-2, pp.173-178, 2014.
DOI : 10.1016/j.jns.2014.06.003

S. Paganoni, E. Macklin, A. Lee, A. Murphy, J. Chang et al., Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS), Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol.139, issue.3, pp.453-459, 2014.
DOI : 10.1016/0022-510X(96)00088-3

C. Scialò, G. Novi, D. Poggio, M. Canosa, A. Sormani et al., Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: An update of LIGALS register, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol.17, issue.7-8, pp.535-577, 2016.
DOI : 10.1002/ana.24096

J. Knibb, N. Keren, A. Kulka, P. Leigh, S. Martin et al., A clinical tool for predicting survival in ALS, Journal of Neurology, Neurosurgery & Psychiatry, vol.87, issue.12, pp.1361-1368, 2016.
DOI : 10.1136/jnnp-2015-312908

Z. Stevic, S. Kostic-dedic, S. Peric, V. Dedic, I. Basta et al., Prognostic factors and survival of ALS patients from Belgrade, Serbia, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol.2, issue.7-8, pp.508-522, 2016.
DOI : 10.1080/14660820500396984

E. Yates and M. Rafiq, Prognostic factors for survival in patients with amyotrophic lateral sclerosis: analysis of a multi-centre clinical trial, Journal of Clinical Neuroscience, vol.32, pp.51-57, 2016.
DOI : 10.1016/j.jocn.2015.12.037

C. Scialò, G. Novi, B. Di-poggio, M. Canosa, A. Sormani et al., Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: An update of LIGALS register, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol.17, issue.7-8, pp.535-577, 2016.
DOI : 10.1002/ana.24096

S. Zoccolella, E. Beghi, G. Palagano, A. Fraddosio, V. Samarelli et al., Signs and symptoms at diagnosis of amyotrophic lateral sclerosis: a population-based study in southern Italy, European Journal of Neurology, vol.13, issue.7, pp.789-92, 2006.
DOI : 10.1016/S0022-510X(99)00019-2

A. Dubrovsky and R. Sica, Current treatment pathways in ALS: a South American perspective, Neurology, vol.53, issue.8, pp.11-16, 1999.

R. Dengler, Current treatment pathways in ALS: a European perspective, Neurology, vol.53, issue.8, pp.4-10, 1999.

M. Galvin, R. Gaffney, B. Corr, I. Mays, and O. Hardiman, From first symptoms to diagnosis of amyotrophic lateral sclerosis: perspectives of an Irish informal caregiver cohort???a thematic analysis, BMJ Open, vol.7, issue.3, p.14985, 2017.
DOI : 10.1136/bmjopen-2016-014985

R. Davenport, R. Swingler, A. Chancellor, and C. Warlow, Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register., Journal of Neurology, Neurosurgery & Psychiatry, vol.60, issue.2, pp.147-51, 1996.
DOI : 10.1136/jnnp.60.2.147

M. Swash, Early diagnosis of ALS/MND, Journal of the Neurological Sciences, vol.160, issue.1, pp.33-36, 1998.
DOI : 10.1016/S0022-510X(98)00215-9

D. Aguila, M. Longstreth, W. Mcguire, V. Koepsell, T. Van-belle et al., Prognosis in amyotrophic lateral sclerosis: A population-based study, Neurology, vol.60, issue.5, pp.813-822, 2003.
DOI : 10.1212/01.WNL.0000049472.47709.3B